InvestorsHub Logo
Followers 1
Posts 92
Boards Moderated 0
Alias Born 02/03/2014

Re: cntmein post# 4389

Wednesday, 02/12/2014 11:59:12 PM

Wednesday, February 12, 2014 11:59:12 PM

Post# of 703825
Would be interesting to know if the mesenchymal subtype is one of the P3's monitored subgroups (i.e. "chances to win"). If pre-defined in the trial design, FDA might be more likely to consider it as a potential subset for post hoc analysis approval (if necessary).
If only downloaded that darned pdf.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News